
The event “AI and biotech: innovation at the service of an increasingly long-lived humanity” is part of the European Biotech Week 2026 program, the European week dedicated to biotechnology and its applications, in which Women&Tech® ETS has been participating for many years, contributing to the dialogue between research, innovation, business, and society.
The increase in life expectancy represents one of the most significant transformations of our time. Living longer means rethinking the concept of health, prevention, care, and quality of life throughout the entire span of life.
In this scenario, biotechnologies and artificial intelligence are opening new possibilities: from personalized medicine to the discovery of new drugs, from the use of data in clinical studies to biotech research in space, up to the definition of regulatory models capable of promoting innovation, safety, and responsible sharing of information.
The event offers a multidisciplinary perspective, bringing together science, technology, clinical research, law, and society through concrete experiences and applications.
Maria Pia Abbracchio will explore the path from telemedicine to the latest applications of artificial intelligence in personalized therapy and the discovery of new drugs.
Ernesto Damiani will present the Amaranth platform and study, demonstrating how AI can help redesign the methods, processes, and tools of clinical studies.
Elena Sgaravatti will broaden the perspective to biotech research in space and its regulatory implications, also focusing on the role of AI in clinical research and biotech therapies through practical examples.
Paola Sangiovanni will finally address the fundamental topic of data sharing, analyzing the role of regulations in enabling the safe and responsible use of information to support research and innovation.
The event is aimed at professionals in research, innovation, healthcare, law, business, and technology, as well as students and individuals interested in understanding how AI and biotech can contribute to building a longer-lasting, sustainable, and inclusive society.
Participating means exploring, through complementary perspectives, some of the most significant transformations today at the intersection of artificial intelligence, biotechnology, and health: from the new frontiers of research and personalized medicine to the evolution of clinical studies, up to the regulatory issues raised by data collection and sharing.
An opportunity to engage with real cases and understand how scientific research, technology, and regulations can evolve together to support a society where living longer also means living better.
We look forward to seeing you.